Cogent Biosciences, Inc. COGT Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s non-cash lease expense?
- Cogent Biosciences, Inc. (COGT) reported non-cash lease expense of $529K in Q1 2026.
- How has Cogent Biosciences, Inc.'s non-cash lease expense changed year-over-year?
- Cogent Biosciences, Inc.'s non-cash lease expense increased by 6.2% year-over-year, from $498K to $529K.
- What is the long-term trend for Cogent Biosciences, Inc.'s non-cash lease expense?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s non-cash lease expense has grown at a -26.3% compound annual growth rate (CAGR), from $5.04M to $2.02M.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.